The rational development of small molecule tachykinin NK3 receptor selective antagonists - the utilisation of a dipeptide chemical library in drug design
- 21 July 1994
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 4 (14) , 1679-1684
- https://doi.org/10.1016/s0960-894x(00)80360-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Rational design of high affinity tachykinin NK2 receptor antagonistsBioorganic & Medicinal Chemistry, 1994
- The design of a dipeptide library for screening at peptide receptor sitesBioorganic & Medicinal Chemistry Letters, 1993
- The rising sun shines on substance P and related peptidesTrends in Pharmacological Sciences, 1993
- Tachykinin receptors and tachykinin receptor antagonistsJournal of Autonomic Pharmacology, 1993
- A general and expedient method for the solid-phase synthesis of 1,4-benzodiazepine derivativesJournal of the American Chemical Society, 1992
- Stabilities of tryptophanylpnenethylamides to acid and alkaline conditions.Bioorganic & Medicinal Chemistry Letters, 1991
- A new type of synthetic peptide library for identifying ligand-binding activityNature, 1991
- Rationally designed "dipeptoid" analogs of CCK. .alpha.-Methyltryptophan derivatives as highly selective and orally active gastrin and CCK-B antagonists with potent anxiolytic propertiesJournal of Medicinal Chemistry, 1991
- Activity of the C-terminal part of substance P on guinea pig ileum and trachea preparations I. N-acylated pentapeptides SP(7–11)European Journal of Medicinal Chemistry, 1988
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977